Indians who have been worried about their future plans to travel to Europe can finally breathe a sigh of relief.
Yesterday (July 1), nine European countries reportedly recognised the Covishield vaccine, which is produced by the Serum Institue of India and is the most-used brand in the country.
The development came on the same day when the European Union started its green pass, which allows anyone who is fully vaccinated with any of the five accepted vaccines—Moderna, Pfizer-BioNTech, Johnson & Johnson, and the AstraZeneca shot manufactured and sold in Europe as Vaxzervria—to travel within the bloc.
Read the rest of this story on qz.com. Become a member to get unlimited access to Quartz’s journalism.